Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2004-10-07 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
关于公司股东持股变动的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a short announcement (1283 characters) about changes in shareholding by company shareholders, specifically detailing the transfer of shares between two shareholders and the updated shareholding percentages. It is titled as a "提示性公告" (prompting announcement) regarding shareholder shareholding changes. There is no financial data, no detailed report, no meeting materials, no voting results, no executive changes, no legal proceedings, no financing updates, and no other detailed financial or management information. The content fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document is not a full report but a brief announcement of shareholding changes, matching MRQ criteria. Confidence is high due to clear match with MRQ definition and absence of other report characteristics.
2004-10-07 Chinese
关于公司股东持股变动的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a detailed announcement about changes in significant shareholdings of the company Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It includes information about share transfers between major shareholders, the number of shares involved, percentages of total share capital, and legal compliance statements referencing the Securities Law and disclosure regulations. The document is not a financial report, earnings release, or management discussion, but a formal notification of changes in major share ownership. This fits the definition of a Major Shareholding Notification (MRQ). The document length is over 6,000 characters and contains substantive details about the shareholding changes, confirming it is not a brief announcement or a report publication notice.
2004-08-13 Chinese
第五届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It reports the decisions made at the fifth board of directors' third meeting, including approval of the 2004 semi-annual report text and summary, and approval of establishing a subsidiary in Hong Kong. The document is short (1485 characters) and primarily announces the board meeting resolutions rather than providing the full semi-annual report or detailed financial data. It also references a related announcement for the associated transaction. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. It is not the full interim report (IR) itself, nor an earnings release or regulatory filing. Therefore, the correct classification is MANG with high confidence.
2004-08-02 Chinese
第五届监事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolution from the company's supervisory board meeting held on August 1, 2004. It mentions the approval of the company's 2004 semi-annual report text and summary, and the establishment of a subsidiary in Hong Kong. The document is short (1233 characters) and serves as a meeting resolution announcement rather than the actual semi-annual report itself. According to the 'Menu vs Meal' rule, this is not the full interim report but an announcement related to it. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2004-08-02 Chinese
关于在香港设立马应龙国际医药发展有限公司之关联交易公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a related party transaction where the company Wuhan Mayinglong Pharmaceutical Group Co., Ltd. plans to establish a subsidiary in Hong Kong with a related party. It details the transaction, the parties involved, the board approval, and the independent directors' opinions. The document is relatively short (2793 characters) and is a formal announcement of a corporate action rather than a financial report or detailed management discussion. It does not contain financial statements or quarterly/yearly results, nor is it a regulatory certification or voting result. The content fits best with a Capital/Financing Update (CAP) as it concerns a capital investment and establishment of a new company entity involving related party transactions.
2004-08-02 Chinese
马 应 龙2004年半年度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2004 年半年度报告' which translates to '2004 Half-Year Report'. It contains detailed financial data including balance sheets, profit and loss statements, management discussion and analysis, shareholder information, and notes on financial performance for the first half of 2004. The document length is substantial (15,000 characters), and it includes unaudited financial statements and comprehensive management commentary. The presence of half-year financial data and management discussion indicates this is an Interim / Quarterly Report rather than a full Annual Report or a simple announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2004
2004-08-02 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.